Somatostatin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09099 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 27 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | amenorrhea (disease) | KG + DL |
| 2 | Leydig cell hypoplasia due to LH resistance | KG + DL |
| 3 | 46,XY disorder of sex development due to impaired androgen production | KG + DL |
| 4 | hypogonadotropic hypogonadism with or without anosmia | KG + DL |
| 5 | multiple endocrine neoplasia | KG + DL |
| 6 | mycotic corneal ulcer | KG + DL |
| 7 | pulmonary hypertension | KG + DL |
| 8 | kyphoscoliotic heart disease | KG + DL |
| 9 | HER2 positive breast carcinoma | KG + DL |
| 10 | homozygous familial hypercholesterolemia | KG + DL |
| 11 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 12 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 13 | hypertrichosis (disease) | KG + DL |
| 14 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 15 | isolated genetic hair shaft abnormality | KG + DL |
| 16 | candidiasis | KG + DL |
| 17 | progesterone-receptor negative breast cancer | KG + DL |
| 18 | progesterone-receptor positive breast cancer | KG + DL |
| 19 | normal breast-like subtype of breast carcinoma | KG + DL |
| 20 | breast tumor luminal A or B | KG + DL |
| 21 | adrenal gland hyperfunction | KG + DL |
| 22 | migraine disorder | KG + DL |
| 23 | malignant catarrh | KG + DL |
| 24 | infectious bovine rhinotracheitis | KG + DL |
| 25 | migraine with brainstem aura | KG + DL |
| 26 | cytomegalovirus infection | KG + DL |
| 27 | oral candidiasis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.